Our case strongly suggests the need to further explore the use of intrapleuralchemotherapy as a novel treatment modality in metastatic cancer with pleural orchest wall diseases, including PTH for HER2+ breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.